HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anil K Sood Selected Research

Intercellular Signaling Peptides and Proteins (Growth Factors)

1/2021Gain-of-function p53 protein transferred via small extracellular vesicles promotes conversion of fibroblasts to a cancer-associated phenotype.
1/2018LPA Induces Metabolic Reprogramming in Ovarian Cancer via a Pseudohypoxic Response.
4/2014Antagonism of tumoral prolactin receptor promotes autophagy-related cell death.
12/2010Suppression of relaxin receptor RXFP1 decreases prostate cancer growth and metastasis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Anil K Sood Research Topics

Disease

430Neoplasms (Cancer)
05/2024 - 08/2002
265Ovarian Neoplasms (Ovarian Cancer)
05/2024 - 07/2002
82Carcinoma (Carcinomatosis)
01/2023 - 08/2002
62Neoplasm Metastasis (Metastasis)
01/2021 - 07/2005
57Ovarian Epithelial Carcinoma
12/2023 - 10/2002
22Endometrial Neoplasms (Endometrial Cancer)
01/2024 - 01/2002
21Breast Neoplasms (Breast Cancer)
01/2023 - 09/2002
16Carcinogenesis
09/2022 - 08/2004
14Hypoxia (Hypoxemia)
11/2023 - 01/2008
13Ascites
12/2023 - 09/2002
12Inflammation (Inflammations)
12/2023 - 06/2007
12Disease Progression
01/2023 - 09/2010
9Uterine Neoplasms (Uterine Cancer)
10/2021 - 04/2014
6Hypertension (High Blood Pressure)
11/2022 - 07/2011
6Uterine Cervical Neoplasms (Cancer of the Cervix)
09/2022 - 04/2002
6Triple Negative Breast Neoplasms
12/2019 - 10/2012
6Colorectal Neoplasms (Colorectal Cancer)
01/2019 - 01/2008
6Fatigue
01/2018 - 09/2010
5Pancreatic Neoplasms (Pancreatic Cancer)
10/2009 - 09/2002
4Granulosa Cell Tumor
01/2024 - 09/2009
4Lung Neoplasms (Lung Cancer)
01/2019 - 03/2014
4Colonic Neoplasms (Colon Cancer)
08/2017 - 07/2005
4Melanoma (Melanoma, Malignant)
01/2016 - 11/2008
4Prostatic Neoplasms (Prostate Cancer)
10/2015 - 12/2010
4Adenocarcinoma
11/2014 - 01/2002

Drug/Important Bio-Agent (IBA)

71Small Interfering RNA (siRNA)IBA
01/2021 - 08/2005
57Proteins (Proteins, Gene)FDA Link
12/2023 - 09/2006
46Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2023 - 08/2002
44MicroRNAs (MicroRNA)IBA
04/2024 - 06/2011
43Biomarkers (Surrogate Marker)IBA
12/2023 - 10/2006
40PlatinumIBA
05/2024 - 08/2003
37Paclitaxel (Taxol)FDA LinkGeneric
01/2023 - 02/2004
27Docetaxel (Taxotere)FDA Link
01/2018 - 02/2004
26Cisplatin (Platino)FDA LinkGeneric
09/2022 - 04/2002
26Adrenergic Agents (Adrenergic Drugs)IBA
07/2020 - 08/2006
211,2-oleoylphosphatidylcholine (DOPC)IBA
01/2019 - 08/2005
20CytokinesIBA
12/2023 - 08/2002
20Interleukin-6 (Interleukin 6)IBA
12/2023 - 07/2005
19Bevacizumab (Avastin)FDA Link
12/2023 - 12/2007
19Messenger RNA (mRNA)IBA
01/2023 - 11/2003
17DNA (Deoxyribonucleic Acid)IBA
07/2022 - 09/2006
17Norepinephrine (Noradrenaline)FDA LinkGeneric
01/2021 - 01/2006
16Hormones (Hormone)IBA
09/2022 - 01/2006
16taxaneIBA
11/2017 - 12/2005
15Phosphotransferases (Kinase)IBA
10/2022 - 08/2004
14RNA (Ribonucleic Acid)IBA
12/2022 - 11/2013
14Focal Adhesion Protein-Tyrosine KinasesIBA
05/2019 - 10/2004
12Hydrocortisone (Cortisol)FDA LinkGeneric
12/2023 - 01/2006
11Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2023 - 07/2015
11Matrix Metalloproteinases (MMPs)IBA
01/2021 - 04/2004
11Liposomes (Liposome)IBA
05/2019 - 08/2005
10ChitosanIBA
11/2022 - 08/2010
10LigandsIBA
01/2020 - 02/2007
10CatecholaminesIBA
10/2018 - 08/2006
9Interleukin-8 (Interleukin 8)IBA
01/2021 - 03/2008
8olaparibIBA
01/2023 - 07/2015
8Carboplatin (JM8)FDA LinkGeneric
10/2021 - 02/2004
8EnzymesIBA
01/2021 - 02/2006
8Adrenergic Receptors (Adrenergic Receptor)IBA
01/2020 - 08/2006
8Monoclonal AntibodiesIBA
01/2020 - 10/2006
7Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2024 - 08/2004
7Topotecan (Hycamtin)FDA LinkGeneric
01/2022 - 09/2004
7Long Noncoding RNAIBA
02/2021 - 10/2013
7Estrogen ReceptorsIBA
12/2019 - 05/2009
7Doxorubicin (Adriamycin)FDA LinkGeneric
01/2019 - 01/2012
7Transcription Factors (Transcription Factor)IBA
10/2018 - 06/2007
7LipidsIBA
01/2018 - 02/2014
7Epinephrine (Adrenaline)FDA LinkGeneric
02/2016 - 01/2006
7afliberceptIBA
01/2016 - 10/2005
7Proliferating Cell Nuclear Antigen (PCNA)IBA
11/2011 - 09/2006
6Therapeutic UsesIBA
01/2023 - 04/2011
6Progesterone Receptors (Progesterone Receptor)IBA
12/2020 - 05/2009
6Indicators and Reagents (Reagents)IBA
01/2015 - 03/2009
6Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA
05/2013 - 08/2006
5Immune Checkpoint InhibitorsIBA
05/2024 - 01/2020
5CollagenIBA
03/2022 - 04/2004
5Dasatinib (BMS 354825)FDA Link
10/2021 - 08/2011
5Taxoids (Taxanes)IBA
01/2020 - 11/2006
5Propranolol (Inderal)FDA LinkGeneric
01/2019 - 01/2006
5ErbB Receptors (EGF Receptor)IBA
11/2017 - 07/2005
5Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
06/2016 - 07/2005
4Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2021 - 12/2010
4Peptides (Polypeptides)IBA
11/2020 - 04/2014
4AntigensIBA
02/2020 - 07/2014
4RNA-Binding Proteins (RNA-Binding Protein)IBA
01/2019 - 09/2014
4Aurora KinasesIBA
01/2018 - 09/2008
4Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2018 - 07/2016
4Angiogenesis InhibitorsIBA
12/2017 - 05/2010
4Tyrosine Kinase InhibitorsIBA
11/2017 - 07/2005
4Histones (Histone)IBA
10/2013 - 09/2008

Therapy/Procedure

189Therapeutics
04/2024 - 01/2002
87Drug Therapy (Chemotherapy)
11/2023 - 07/2004
18Neoadjuvant Therapy
11/2023 - 07/2009
13Cytoreduction Surgical Procedures
01/2024 - 07/2004
8Radiotherapy
09/2022 - 02/2010
8Immunotherapy
01/2021 - 07/2014
8Hysterectomy
01/2017 - 10/2002
7Lasers (Laser)
07/2021 - 01/2011
6Lymph Node Excision (Lymph Node Dissection)
09/2017 - 04/2009
4Aftercare (After-Treatment)
09/2022 - 12/2005